Is The New Oxycontin Abuse Proof?


	Is The New Oxycontin Abuse Proof?

Matthew Herper

5-6-2008 9:38 AM

623 views

Matthew Herper says:

According to the Wall Street Journal, a panel of FDA advisers was skeptical and one said the lack of data was "almost insulting."

Add a Comment

Login to Comment. Not a member yet? Sign up

View the Top Clips from May 6, 2008

Embed This Clip In Your Site...

<div style="margin: 12px 0px; font-family: arial; color: #333333; background: #ffffff; border: solid 4px #e5e5e5; width: 100%; clear: left;"><div class="CM_CTB_Content_Wrap" style="margin: 0px; padding: 0px;background-color: #ffffff;"><div style="border-bottom: solid 1px #dcdcdc; white-space: nowrap; margin-bottom: 8px; background-color: #eeeeee ;background-image: url(http://www.clipmarks.com/images/source-bg.gif); background-repeat: repeat-x; height: 24px; line-height: 24px; vertical-align: middle; padding-bottom: 4px; color: #666666; font-size: 10px;" ><a href="http://clipmarks.com/clip-to-blog/" title="see clips that are hot right now"><img src="http://content.clipmarks.com/blog_embed/a8189abb-dcd4-455c-be05-9b123a646dcd/E0EA256C-E0AB-489E-A5A5-C4DF82DED215/" alt="" width="19" height="19" border="0" style="vertical-align: middle; margin: 0px 4px; display: inline; border: none; float:none;" /></a>clipped from <a title="http://online.wsj.com/article/SB121001158320368221.html?mod=WSJBlog" href="http://online.wsj.com/article/SB121001158320368221.html?mod=WSJBlog" style="font-size: 11px;">online.wsj.com</a></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://online.wsj.com/article/SB121001158320368221.html?mod=WSJBlog"><P class="times">A Food and Drug Administration panel expressed deep concerns about a purported abuse-resistant form of the painkiller OxyContin, saying there is a "striking" lack of data about the drug's abuse-prevention qualities.</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://online.wsj.com/article/SB121001158320368221.html?mod=WSJBlog"><P class="times">"I'm fascinated with the poor scientific rigor" of the data presented by Purdue Pharma LP, maker of OxyContin, FDA panel member Jeffrey R. Kirsch said. "It's almost insulting."</P></blockquote><div style="height: 2px; font-size: 2px; background: #dcdcdc; border-bottom: solid 1px #f5f5f5; margin: 2px 4px;"></div><blockquote style="text-align: left; padding: 0px 8px; margin: 4px 0px 8px 0px; background: transparent; border: none;" cite="http://online.wsj.com/article/SB121001158320368221.html?mod=WSJBlog"><P class="times">Purdue Pharma, based in Stamford, Conn., is seeking FDA approval for the abuse-resistant form of OxyContin, which is of a lower strength than some other forms on the market. An FDA panel Monday was considering whether the drug has enough abuse-resistant features to be allowed on the market before required long-term studies are done, and whether those qualities should be included on the label. No vote, however, was scheduled or taken.</P></blockquote></div><div style="margin: 0px 6px 6px 4px;"><table style="font-size: 11px;border-spacing: 0px;padding: 0px;" cellpadding="0" cellspacing="0" width="100%"><tr><td style="background:transparent;border-width:0px;padding:0px;">&nbsp;</td><td align="right" style="background:transparent;border-width:0px;padding:0px;width:107px" width="107"><a href="http://clipmarks.com/share/E0EA256C-E0AB-489E-A5A5-C4DF82DED215/blog/" title="blog or email this clip"><img src="http://content8.clipmarks.com/images/c2b-foot.png" border="0" alt="blog it" width="107" height="17" style="border-width:0px;padding:0px;margin:0px;" /></a></td></tr></table></div></div>

Clipmarks: Home; New Clips; Top Clips; Dashboard

Popular Topics: News; Life; Science; Technology; Entertainment

Get Started: Sign Up; Install Clipping Tool; How Clipping Works; Clip-to-Blog™; ClipSearch

Tools and Resources: FAQ; ClipWeek; Top Clippers; Top Tags; Site Map

About Clipmarks: About Us; Contact; Blog; Copyright; Privacy; EULA

Search Options

Related Clips

More clips from Matthew Herper

Today's Top Clips